ATE275126T1 - 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen - Google Patents

2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen

Info

Publication number
ATE275126T1
ATE275126T1 AT99913563T AT99913563T ATE275126T1 AT E275126 T1 ATE275126 T1 AT E275126T1 AT 99913563 T AT99913563 T AT 99913563T AT 99913563 T AT99913563 T AT 99913563T AT E275126 T1 ATE275126 T1 AT E275126T1
Authority
AT
Austria
Prior art keywords
acid derivatives
preparations containing
methylpropionic acid
containing same
medical preparations
Prior art date
Application number
AT99913563T
Other languages
English (en)
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Harunobu Mukaiyama
Akihito Hirabayashi
Hideyuki Muranaka
Masaaki Sato
Masuo Akahane
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of ATE275126T1 publication Critical patent/ATE275126T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99913563T 1998-04-14 1999-04-07 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen ATE275126T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14202898 1998-04-14
PCT/JP1999/001836 WO1999052856A1 (en) 1998-04-14 1999-04-07 2-methylpropionic acid derivatives and medicinal compositions containing the same

Publications (1)

Publication Number Publication Date
ATE275126T1 true ATE275126T1 (de) 2004-09-15

Family

ID=15305697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913563T ATE275126T1 (de) 1998-04-14 1999-04-07 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen

Country Status (19)

Country Link
US (2) US6696489B1 (de)
EP (1) EP1072583B1 (de)
JP (1) JP4212771B2 (de)
KR (1) KR100576131B1 (de)
AR (1) AR015761A1 (de)
AT (1) ATE275126T1 (de)
AU (1) AU768217C (de)
CA (1) CA2328348C (de)
CO (1) CO5021214A1 (de)
DE (1) DE69919860T2 (de)
ES (1) ES2228028T3 (de)
IL (1) IL138994A (de)
MY (1) MY122400A (de)
NO (1) NO20005164L (de)
NZ (1) NZ507486A (de)
PE (1) PE20000423A1 (de)
TW (1) TW581754B (de)
WO (1) WO1999052856A1 (de)
ZA (1) ZA200005589B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376707B1 (en) * 1999-01-21 2002-04-23 Kissei Pharmaceutical Co., Ltd. Crystal polymorphism of aminoethylphenoxyacetic acid derivative
CA2503570C (en) 2002-11-07 2011-04-19 Yamanouchi Pharmaceutical Co., Ltd. Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
BRPI0407386A (pt) * 2003-02-14 2006-02-07 Kissei Pharmaceutical Derivados de álcool de amino, composições farmacêuticas contendo os mesmos e uso destes
ITMI20061581A1 (it) * 2006-08-04 2008-02-05 Univ Bari Ligandi del recettore beta-3 adrenergico e loro uso in terapia
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
ES2665467T3 (es) 2010-03-29 2018-04-25 Astellas Pharma Inc. Composición farmacéutica de liberación modificada
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4338333A (en) 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
FR2750668B1 (fr) 1996-07-03 1998-11-20 Savard Franck Dispositif de tension et de guidage d'une chaine pour un changement de vitesses de velo
WO1998013333A1 (en) * 1996-09-26 1998-04-02 Kissei Pharmaceutical Co., Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives
ID24062A (id) * 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
ATE250570T1 (de) * 1997-12-18 2003-10-15 Kissei Pharmaceutical Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten

Also Published As

Publication number Publication date
ZA200005589B (en) 2002-01-11
US6696489B1 (en) 2004-02-24
EP1072583A1 (de) 2001-01-31
EP1072583B1 (de) 2004-09-01
CA2328348A1 (en) 1999-10-21
AR015761A1 (es) 2001-05-16
CA2328348C (en) 2009-03-03
PE20000423A1 (es) 2000-05-22
NO20005164D0 (no) 2000-10-13
CO5021214A1 (es) 2001-03-27
WO1999052856A1 (en) 1999-10-21
US6790865B2 (en) 2004-09-14
IL138994A0 (en) 2001-11-25
AU3166199A (en) 1999-11-01
NZ507486A (en) 2003-03-28
MY122400A (en) 2006-04-29
AU768217C (en) 2005-04-21
JP4212771B2 (ja) 2009-01-21
DE69919860D1 (de) 2004-10-07
KR100576131B1 (ko) 2006-05-03
US20030166719A1 (en) 2003-09-04
DE69919860T2 (de) 2005-08-25
KR20010042683A (ko) 2001-05-25
TW581754B (en) 2004-04-01
IL138994A (en) 2004-02-19
AU768217B2 (en) 2003-12-04
ES2228028T3 (es) 2005-04-01
EP1072583A4 (de) 2001-12-05
NO20005164L (no) 2000-12-12

Similar Documents

Publication Publication Date Title
EP0731712A4 (de) Physiologisch stabile butlersäurepräparate, und butlersäuresalze und -derivate als antineoplastische wirkstoff
DE69815833D1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
DE69906732D1 (de) Bleichkatalysatoren und sie enthaltende formulierungen
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
DE69432971D1 (de) Trokar und kanüle
DE69727329T2 (de) Medizinische Elektrode
DE69424853D1 (de) Morphinan-derivate und ihre medizinische verwendung
DE59401563D1 (de) Medizinische Zange
EP0950665A4 (de) Veränderte physiologisch aktive proteine und medizinische verbindungen, die diese beinhalten
ATE240315T1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE69419601D1 (de) Aminderivate und sie enthaltende dermatologische zubereitungen
DE69416332D1 (de) Einführungsstilett für medizinsche kanüle und kanüle
DE69730723D1 (de) Medizinische aerosolformulierungen von formoterol
HUP0103793A3 (en) N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them
DE69931799D1 (de) Absorptionsbeschleuniger und diese enthaltende zubereitungen zur transdermalen absorption
DE69625326D1 (de) Anthracyclinderivate und sie enthaldende medizinische zubereitungen
DE59808804D1 (de) Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE69705324D1 (de) N-hydroxyharnstoffderivate und sie enthaltende medizinische zubereitungen
EE05000B1 (et) 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
IL136612A0 (en) Phenylaminoalkylcarboxylic acid derivatives and medical compositions containing the same
DE69919860D1 (de) 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen
ATE298576T1 (de) Arzneizubereitungen
NO931342D0 (no) Benzimidazoler, medisinske preparater inneholdende disse,og fremgangsmaate for deres fremstilling

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties